Table 5 Prognostic factors for RIC... | American Society of Hematology

Table 5

Prognostic factors for RIC transplantation

Outcome	Progressive disease		Alemtuzumab		T-cell depletion*
Outcome	HR	P	HR	P	HR	P
Survival	2.0	< .001	1.8	.005	ns	ns
PFS	1.9	< .001	1.8	.001	ns	ns
Relapse	1.9	.02	2.3	.001	1.6	.03
NRM	1.9	.01	ns	ns	ns	ns

Outcome	Progressive disease		Alemtuzumab		T-cell depletion*
Outcome	HR	P	HR	P	HR	P
Survival	2.0	< .001	1.8	.005	ns	ns
PFS	1.9	< .001	1.8	.001	ns	ns
Relapse	1.9	.02	2.3	.001	1.6	.03
NRM	1.9	.01	ns	ns	ns	ns

Excluding alemtuzumab.